Status of Current Biofluid Biomarkers in Parkinson's Disease.
作者信息
Mollenhauer Brit
机构信息
Department of Neurology University Medical Center Göttingen Göttingen Germany.
Paracelsus-Elena-Klinik Kassel Germany.
出版信息
Mov Disord Clin Pract. 2023 May 19;10(Suppl 2):S18-S20. doi: 10.1002/mdc3.13753. eCollection 2023 Aug.
Abstract
摘要
相似文献
1
Status of Current Biofluid Biomarkers in Parkinson's Disease.帕金森病当前生物流体生物标志物的现状
Mov Disord Clin Pract. 2023 May 19;10(Suppl 2):S18-S20. doi: 10.1002/mdc3.13753. eCollection 2023 Aug.
2
Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid.帕金森病的诊断生物标志物：聚焦于脑脊液中的 α-突触核蛋白。
Parkinsonism Relat Disord. 2019 Feb;59:21-25. doi: 10.1016/j.parkreldis.2018.11.016. Epub 2018 Nov 15.
3
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).多中心组织和生物液 α-突触核蛋白取样用于帕金森病的可行性和安全性：系统性突触核蛋白取样研究（S4）。
J Parkinsons Dis. 2018;8(4):517-527. doi: 10.3233/JPD-181434.
4
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.独立的α-突触核蛋白种子扩增检测方法对早期帕金森病的高诊断性能。
Acta Neuropathol Commun. 2021 Nov 6;9(1):179. doi: 10.1186/s40478-021-01282-8.
5
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.检测毒性 α-突触核蛋白作为帕金森病生物标志物的方法。
Crit Rev Clin Lab Sci. 2020 Aug;57(5):291-307. doi: 10.1080/10408363.2019.1711359. Epub 2020 Mar 1.
6
Parkinson's disease biomarkers based on α-synuclein.基于α-突触核蛋白的帕金森病生物标志物。
J Neurochem. 2019 Sep;150(5):626-636. doi: 10.1111/jnc.14809. Epub 2019 Jul 28.
7
Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.帕金森病患者的泪液中 α-突触核蛋白和神经丝轻链水平升高，视网膜微血管密度降低。
Geroscience. 2022 Jun;44(3):1551-1562. doi: 10.1007/s11357-022-00576-6. Epub 2022 Apr 28.
8
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.DJ-1 和α-突触核蛋白在人脑脊液中作为帕金森病的生物标志物。
Brain. 2010 Mar;133(Pt 3):713-26. doi: 10.1093/brain/awq008. Epub 2010 Feb 15.
9
Serological Analysis of Alpha-synuclein and NF-κB in Parkinson's Disease Patients.帕金森病患者中α-突触核蛋白和核因子κB的血清学分析
J Clin Diagn Res. 2015 May;9(5):BC01-4. doi: 10.7860/JCDR/2015/12545.5978. Epub 2015 May 1.
10
Detection of neuron-derived pathological α-synuclein in blood.血液中神经元衍生的病理性 α-突触核蛋白的检测。
Brain. 2022 Sep 14;145(9):3058-3071. doi: 10.1093/brain/awac115.
引用本文的文献
1
Smartphone-derived multidomain features including voice, finger-tapping movement and gait aid early identification of Parkinson's disease.源自智能手机的多领域特征，包括语音、手指敲击动作和步态，有助于早期识别帕金森病。
NPJ Parkinsons Dis. 2025 May 5;11(1):111. doi: 10.1038/s41531-025-00953-w.
2
A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease.变革的呼声：更新帕金森病痴呆的操作定义
Mov Disord Clin Pract. 2025 Mar;12(3):296-301. doi: 10.1002/mdc3.14305. Epub 2024 Dec 17.
3
Exploring Acoustic Detection of α-Synuclein Fibrils.探索α-突触核蛋白原纤维的声学检测
Protein J. 2025 Feb;44(1):62-67. doi: 10.1007/s10930-024-10241-w. Epub 2024 Dec 4.
4
An immunoassay for the quantification of phosphorylated α-synuclein at serine 129 in human cerebrospinal fluid.一种用于定量检测人脑脊液中磷酸化α-突触核蛋白丝氨酸 129 的免疫分析方法。
Bioanalysis. 2024;16(21-22):1125-1139. doi: 10.1080/17576180.2024.2407718. Epub 2024 Oct 15.
5
Unraveling Metabolic Changes following Stroke: Insights from a Urinary Metabolomics Analysis.揭示中风后的代谢变化：来自尿液代谢组学分析的见解
Metabolites. 2024 Feb 28;14(3):145. doi: 10.3390/metabo14030145.
6
Unanswered Questions in Clinical Practice.临床实践中的未解问题。
Mov Disord Clin Pract. 2023 Aug 4;10(Suppl 2):S5-S8. doi: 10.1002/mdc3.13837. eCollection 2023 Aug.
本文引用的文献
1
Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease.唾液α-突触核蛋白实时无细胞扩增检测与新发帕金森病的疾病严重程度相关。
Mov Disord. 2023 Jan;38(1):153-155. doi: 10.1002/mds.29246. Epub 2022 Oct 19.
2
Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: A systematic review and meta-analysis.唾液α-突触核蛋白作为帕金森病潜在的液体生物标志物：一项系统评价和荟萃分析。
Aging Med (Milton). 2022 Jan 24;5(1):53-62. doi: 10.1002/agm2.12192. eCollection 2022 Mar.
3
Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.唾液实时液滴震荡转换检测在帕金森病和多系统萎缩中的诊断价值。
Mov Disord. 2022 May;37(5):1059-1063. doi: 10.1002/mds.28976. Epub 2022 Mar 12.
4
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.通过 RT-QuIC 在孤立性快速眼动睡眠行为障碍患者的 CSF 中检测 α-突触核蛋白：一项纵向观察性研究。
Lancet Neurol. 2021 Mar;20(3):203-212. doi: 10.1016/S1474-4422(20)30449-X.
5
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.血清神经丝轻链作为帕金森病进展的生物标志物的验证。
Mov Disord. 2020 Nov;35(11):1999-2008. doi: 10.1002/mds.28206. Epub 2020 Aug 15.
6
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.鉴别帕金森病和多系统萎缩中的α-突触核蛋白菌株。
Nature. 2020 Feb;578(7794):273-277. doi: 10.1038/s41586-020-1984-7. Epub 2020 Feb 5.
7
Blood NfL: A biomarker for disease severity and progression in Parkinson disease.血液 NfL：帕金森病疾病严重程度和进展的生物标志物。
Neurology. 2019 Sep 10;93(11):e1104-e1111. doi: 10.1212/WNL.0000000000008088. Epub 2019 Aug 16.
8
Update of the MDS research criteria for prodromal Parkinson's disease.前驱帕金森病 MDS 研究标准的更新。
Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14.
9
Dyskinesia in multiple system atrophy and progressive supranuclear palsy.多系统萎缩和进行性核上性麻痹中的运动障碍。
J Neural Transm (Vienna). 2019 Jul;126(7):925-932. doi: 10.1007/s00702-019-02012-0. Epub 2019 May 13.
10
Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease.对比研究脑脊液α-突触核蛋白种子聚合分析在帕金森病诊断中的应用。
Mov Disord. 2019 Apr;34(4):536-544. doi: 10.1002/mds.27646. Epub 2019 Mar 6.
Zotero 插件